Biological Surrogates for Enhancing Cardiovascular Risk Prediction in Type 2 Diabetes Mellitus
- 19 February 2007
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 99 (4) , 80-88
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Type 2 Diabetes as a “Coronary Heart Disease Equivalent”Diabetes Care, 2005
- Should Diabetes Be Considered a Coronary Heart Disease Risk Equivalent?Diabetes Care, 2005
- Cardiovascular Events in Diabetic and Nondiabetic Adults With or Without History of Myocardial InfarctionCirculation, 2004
- Association of the Metabolic Syndrome With History of Myocardial Infarction and Stroke in the Third National Health and Nutrition Examination SurveyCirculation, 2004
- Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studiesBMJ, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Diabetes and All-Cause and Coronary Heart Disease Mortality Among US Male PhysiciansArchives of internal medicine (1960), 2001
- Physical Activity and Risk for Cardiovascular Events in Diabetic WomenAnnals of Internal Medicine, 2001
- Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial InfarctionCirculation, 2000
- Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial InfarctionNew England Journal of Medicine, 1998